Cargando…
New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges
SIMPLE SUMMARY: YES-associated protein (YAP) is a co-transcriptional activator that binds to transcriptional factors to increase the rate of transcription of a set of genes, and it can intervene in the onset and progression of different tumors. Most of the data in the literature refer to the effects...
Autores principales: | Allegra, Alessandro, Pioggia, Giovanni, Innao, Vanessa, Musolino, Caterina, Gangemi, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073623/ https://www.ncbi.nlm.nih.gov/pubmed/33924049 http://dx.doi.org/10.3390/cancers13081981 |
Ejemplares similares
-
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
por: Allegra, Alessandro, et al.
Publicado: (2019) -
Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges
por: Allegra, Alessandro, et al.
Publicado: (2020) -
Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021) -
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
por: Musolino, Caterina, et al.
Publicado: (2017) -
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
por: Allegra, Andrea Gaetano, et al.
Publicado: (2020)